BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26261257)

  • 41. Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinoma.
    Suda K; Sato K; Shimizu S; Tomizawa K; Takemoto T; Iwasaki T; Sakaguchi M; Mitsudomi T
    Biomed Res Int; 2014; 2014():645681. PubMed ID: 25371901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.
    Lee HY; Lee SW; Lee KS; Jeong JY; Choi JY; Kwon OJ; Song SH; Kim EY; Kim J; Shim YM
    J Thorac Oncol; 2015 Dec; 10(12):1785-94. PubMed ID: 26473646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
    Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
    Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.
    Kudo Y; Shimada Y; Saji H; Kato Y; Yoshida K; Matsubayashi J; Nagase S; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Clin Lung Cancer; 2015 Nov; 16(6):e213-21. PubMed ID: 25986624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma.
    Yoshiya T; Mimae T; Tsutani Y; Tsubokawa N; Sasada S; Miyata Y; Kushitani K; Takeshima Y; Murakami S; Ito H; Nakayama H; Okada M
    Ann Thorac Surg; 2016 Nov; 102(5):1668-1673. PubMed ID: 27344277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component.
    Li J; You W; Zheng D; Yan B; Ma X; Pan Y; Zhang Y; Li Y; Shen X; Cheng X; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):725-734. PubMed ID: 29368062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.
    Zhao ZR; Xi SY; Li W; Situ DR; Chen KM; Yang H; Su XD; Lin YB; Long H
    Lung Cancer; 2015 Dec; 90(3):604-9. PubMed ID: 26547801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solid component and tumor size correlate with prognosis of stage IB lung adenocarcinoma.
    Xu S; Xi J; Jiang W; Lu S; Wang Q
    Ann Thorac Surg; 2015 Mar; 99(3):961-7. PubMed ID: 25633461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.
    Mansuet-Lupo A; Bobbio A; Blons H; Becht E; Ouakrim H; Didelot A; Charpentier MC; Bain S; Marmey B; Bonjour P; Biton J; Cremer I; Dieu-Nosjean MC; Sautès-Fridman C; Régnard JF; Laurent-Puig P; Alifano M; Damotte D
    Chest; 2014 Sep; 146(3):633-643. PubMed ID: 24676429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
    Villa C; Cagle PT; Johnson M; Patel JD; Yeldandi AV; Raj R; DeCamp MM; Raparia K
    Arch Pathol Lab Med; 2014 Oct; 138(10):1353-7. PubMed ID: 24571650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
    Lococo F; Galeone C; Formisano D; Bellafiore S; Filice A; Annunziata T; Cesario A; Rapicetta C; Fioroni F; Ricchetti T; Paci M
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):667-673. PubMed ID: 28043987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of histologic subtyping on outcome in lobar vs sublobar resections for lung cancer: a pilot study.
    Dembitzer FR; Flores RM; Parides MK; Beasley MB
    Chest; 2014 Jul; 146(1):175-181. PubMed ID: 24556743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samples.
    Fujimoto Y; Togo S; Tulafu M; Shimizu K; Hayashi T; Uekusa T; Honma Y; Namba Y; Takamochi K; Oh S; Suzuki K; Takahashi K
    Int J Clin Exp Pathol; 2015; 8(9):10523-33. PubMed ID: 26617762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.
    Sakurai H; Asamura H; Miyaoka E; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):100-7. PubMed ID: 23729748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between lung adenocarcinoma histological subtype and patient prognosis.
    Urer HN; Kocaturk CI; Gunluoglu MZ; Arda N; Bedirhan MA; Fener N; Dincer SI
    Ann Thorac Cardiovasc Surg; 2014; 20(1):12-8. PubMed ID: 23364232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.
    Gao S; Stein S; Petre EN; Shady W; Durack JC; Ridge C; Adusumilli P; Rekhtman N; Solomon SB; Ziv E
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):253-259. PubMed ID: 28770314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Chest; 2013 Jun; 143(6):1626-1634. PubMed ID: 23348916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases.
    Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
    Clin Lung Cancer; 2015 May; 16(3):209-15. PubMed ID: 25467929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.